Literature DB >> 30918360

Recombinant IL-1Ra as first-line therapy in sJIA.

Joanna Collison1.   

Abstract

Entities:  

Year:  2019        PMID： 30918360     DOI： 10.1038/s41584-019-0208-8

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.

Authors:  Nienke M Ter Haar; E H Pieter van Dijkhuizen; Joost F Swart; Annet van Royen-Kerkhof; Ayman El Idrissi; Arjen P Leek; Wilco de Jager; Mark C H de Groot; Saskia Haitjema; Dirk Holzinger; Dirk Foell; Jorg van Loosdregt; Nico M Wulffraat; Sytze de Roock; Sebastiaan J Vastert
Journal:  Arthritis Rheumatol       Date:  2019-05-25       Impact factor: 10.995
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.